Year: 2009
Type: erratum
Abstract: Original article, “Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.”Int J Clin Pract 2009; 63: 1395–406. In the Appendix of the above mentioned article (1) on pages 1405 and 1406, KC Shih is listed as being from Thailand but should be listed as being from Taiwan. The corrected list is printed below. APPENDIX CV181-040 Study Investigators: Argentina: Fideleff H, Maffei L, Migueles J, Sposetti G, Ulla MR, Waitman J; Brazil: Chacra AR, Eliaschewitz F, Felicio J, Forti A, Gross JL, Hissa MN, Purish S, Repetto G, Saraiva JF, Sgarbi JA; Hong Kong: Lee KF, Tong P; Israel: Adawi F, Buchs A, Cohen J, Harman Bohem I, Karnieli E, Klainman E, Raz I, Wainstein J, Yerushalmy Y; Mexico: Aguilera M, Alvarado R, Calvo C, Gonzalez G, Gonzalez Gonzalez G, Jerjes-Sanchez C, Medina Pech CE, Robles FJ, Saldate C, Sauque Reyna L; Peru: Caballero J, Villena J, Zapata L, Zubiate C; Philippines: Jasul G, Lim-Abrahan MA, Pacheco E, Tan GH; Puerto Rico: Abreu-Feshold F, Barranco Santana E, Claudio J, Vazquez Tanus JB; Republic of Korea: Ahn CW, Jang HC, Lee HC, Lee KW, Lee MK, Park JS, Woo JT, Yoo SJ, Yoon KH; Singapore: Lee KO; South Africa: Bernhardi D, Bhana SA, Burgess L, Chetty S, Distiller L, Kaplan H, Khutsoane DT, Moore R, Mynhardt JH; Taiwan: Chuang LM, Ho LT, Huang CN, Lin KC, Shih KC; United States: Acampora MD, Adams J, Arnold G, Aventa A, Azorr M, Barrera JE, Bedel G, Bolick C, Brautigam D, Brinson AC, Catlett D, Chappel C, Chrysant S, Cohen K, Corbett III B, Damian D, Dass B, Diederich CF, Doolan R, Dyck D, Eberly J, Ellis C, Ganong KD, Goldberg R, Gray WL, Guthrie R, Harrison B, Hendley L, Hershberger VJ, Hoekstra JA, Hoyte S, Hurley S, Isakov T, Ison R, Jacks WP, Jain RK, Johnson D, Joiner J, Kayne D, Kayota SW, Landgarten S, Latham G, Lee FJ, Lenhard J, Lockwood RJ, Lucas KJ, McKeown-Biagas C, Mercado A, Michael B, Miller AB, Miller S, Mitchell JR, Montoro R, Morales L, Nagaria A, Norwood Jr P, Nurnberg RD, Patel M, Pearlstein P, Pearson D, Pudi KK, Rhudy J, Rigonan K, Ryan WM, Saway W, Schwartz SL, Shealy N, Sher L, Shue RG, Simon H, Sloan GK, Snyder B, Soufer J, Spence JA, Stevens JA, Sugimoto DH, Tarshis G, Trevino M, Wayne J, Weisbrot AJ, Wiegmann T, Witkin DB.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Pfizer, Boehringer Ingelheim España
OpenAlex ID: W4240536607
